| Pages | ||||
|---|---|---|---|---|
| Report ofthe Chair | 2-3 | |||
| Report ofthe Trustees | 4-14 | |||
| Independent Auditor's |
Report | 15-20 | ||
| Statement of FinancialActi | dtles | (including the Income and Expenditure | account) | |
| Balance Sheet | 22-23 | |||
| Statement ofCash Flows | 24 | |||
| Notes to rhe Financial | Statements | 25-36 |
| AR ENDED 31MARCH 2 | 023 | |||||
|---|---|---|---|---|---|---|
| Unrestricted | Restricted | Total funds | Total funds | |||
| Note | Income Fund |
Income | 2023 | 2022 | ||
| Fund | ||||||
| Income and endowments | from: | |||||
| Donations and legacies |
586,627 | 497,995 | 1,084,622 | 1,053,821 | ||
| Activities for generating | funds | 254,711 | 254,711 | 172,872 | ||
| Investments | 23,992 | 23,992 | 535 | |||
| Total income and endowments | 865,330 | 497,995 | 1,363,325 | 1,227,228 | ||
| Expenditure on: |
||||||
| Raising funds | 7 | 277,217 | 277,217 | 265,093 | ||
| Charitable activities |
7 | 450,315 | 628,235 | 1,078,550 | 796,242 | |
| Total expenditure | 7 | 727,532 | 628,235 | 1,355,767 | 1,061,335 | |
| Net gains/(losses) on investments |
(12,440) | (12,440) | 104,658 | |||
| Net income/(expenditure) | 125,358 | [130,240) | (4,882) | 270,551 | ||
| Transfers between funds |
||||||
| Net movement in funds |
125,358 | (130,240) | (4,882) | 270,551 | ||
| Recondliation offunds: |
||||||
| Total Funds at31March | 2022 | 2,096,785 | 282,167 | 2,378,952 | 2,108,401 | |
| Total funds at31March | 2023 | 2,222,143 | 151,927 | 2,374,070 | 2,378,952 |
| 31MARCH | 2023 | |||||||
|---|---|---|---|---|---|---|---|---|
| Unrestricte | Restricted | Total | Total | |||||
| Note | d Income | Income | funds | funds | ||||
| Fund | Fund | 2023 | 2022 | |||||
| Fixed assets | ||||||||
| Tangible assets | 1'1 | 9,240 | 9,240 | 12,104 | ||||
| Investments | 12 | 1,826,007 | 613,453 | 2,439,460 | 2,433,525 | |||
| 1,835,247 | 613,453 | 2,448,700 | 2,445,629 | |||||
| Current assets | ||||||||
| Stocks | 13 | 13,012 | 13,012 | 8,505 | ||||
| Debtors | 14 | 145,694 | 145,694 | 64,874 | ||||
| Cash at bank | and in | hand | 15 | 270,321 | 270,321 | 339,096 | ||
| 429,027 | 429,027 | 412,475 | ||||||
| Liabilities: | ||||||||
| Creditors: Amounts | falling due vvithin one | 16 | (42,131) | (222,018) | (264,'149) | (239,787) | ||
| year | ||||||||
| Net current | assets/(liabilities) | 386,896 | (222,018) | 164,878 | 172,688 | |||
| Total assets | less current | liabilities | 2,222,143 | 391,435 | 2,613,578 | 2,618,317 | ||
| Creditors: Amounts | falling due after more | 17 | (239,508) | (239,508) | (239,365) | |||
| than one year | ||||||||
| Net assets/(liabilities) | 2,222,143 | 151,927 | 4374,070 | 2,378,952 | ||||
| Charity Funds | ||||||||
| Unrestricted | funds | 2,216,208 | 2,216,208 | 1,991,656 | ||||
| Revaluation | reserve | 5,935 | 5,935 | 105,129 | ||||
| Restricted funds | 22 | 151,927 | 151,927 | 282,167 | ||||
| Total charity | funds | 2,222,143 | 151,927 | 2,374,070 | 2,378,952 |
| Total funds | Total funds | |||
|---|---|---|---|---|
| Note | 2023 | 2022 | ||
| E | ||||
| carhflow from operating | activities | 18 | (71,900) | 154,0S1 |
| Cash flew from investing | activities | |||
| Interest received | 23,992 | S35 | ||
| Payments to acquire oftangible fixed assets | (2,492) | (6,489) | ||
| Receipts from sales oftangible assets | ||||
| Payments to acquire investments | (18,375) | (471) | ||
| Receipts from sale ofinvestments | ||||
| Net cash flow from investing activities |
3,125 | (6,425) | ||
| Change in cash and cash equivalents |
(68,775) | 147,626 | ||
| Cash and cash equivalents | brought forward |
339,096 | 191,470 | |
| Cash and cash equivalents | carried forward | 270,321 | 339,096 | |
| Cash and cash equivalents | consist of; | |||
| Cash at bank and in hand | 270,321 | 339,096 | ||
| Short term deposits | ||||
| Cash and cash equivalents | at31March 2023 | 270,321 | 339,096 |
| Income | from donations and legacies |
||||
|---|---|---|---|---|---|
| Unrestricted | Restricted | Total | Total | ||
| Income | Incan)e | 2023 | 2022 | ||
| Fund | Fund | ||||
| f | E | f | f | ||
| Donatians | and legacies | ||||
| Donations | under the Gift Aid scheme | 76,385 | 76,385 | 64,933 | |
| Legacy donations | 43,497 | 43,497 | 135,408 | ||
| Memoriam | donations | '213,585 | 3,635 | 217,220 | 218,494 |
| Other danations | 253,160 | 494,360 | 747,520 | 634,986 | |
| '586,627 | 497,995 | 1,084,622 | 1,053,821 |
| Unrestricted | Restricted | Total | Total | |
|---|---|---|---|---|
| Income | Income | 2023 | 2022 | |
| Fund | Fund | |||
| Event income | 241,374 | 241,374 | 158,410 | |
| Merchandise | 13,337 | 13,337 | 14,462 | |
| 254,711 | 254,711 | 172,872 |
| Investment inc |
ome | |||||
|---|---|---|---|---|---|---|
| Unrestricted | Restricted | Total | Total | |||
| Income | Income | 2023 | 2022 | |||
| Fund | Fund | |||||
| E | E | E | E | |||
| Interest receivable | from UK deposg | account | 2,303 | 2,303 | 535 | |
| income receivable | from investment | fund | 21,689 | 21,689 | ||
| managers | ||||||
| 23,992 | 23,992 | 535 |
| Net inco | me/(expenditu | re) and n |
et movemarns in funds have |
been stated after charging | : |
|---|---|---|---|---|---|
| Total | Total | ||||
| 2023 | 2022 | ||||
| Depreciation | oftangible | fixed assets | 5,356 | 4,629 | |
| (Profit)/loss | on fair value | movement | ofinvestments | 12,440 | (104,658) |
| . Analysis ofreso |
urces expended | ||
|---|---|---|---|
| Total | Total | ||
| 2023 | 2022 | ||
| Cost ofgenerating | funds | ||
| Merchandise | 3,605 | 4,218 | |
| Events and catering | 12,912 | 5,907 | |
| Salaries | 133,962 | 139,757 | |
| PR and Marketing | 5,772 | 3,560 | |
| Support costs | 120,966 | 111,651 | |
| 277,217 | 265,093 |
| Direct | Support | Total | Total | ||
|---|---|---|---|---|---|
| activities | costs | 2023 | 2022 | ||
| f | f | f | |||
| Charitable | aclivities | ||||
| Research | 473,579 | 19,245 | 492,824 | 307,836 | |
| Info and patient support | 451,015 | 134,711 | 585,726 | 488,406 | |
| 924,594 | 153,956 | 1,078,550 | 796,242 |
| Cost of | Research | Info and | Total | |||
|---|---|---|---|---|---|---|
| generating | patient | |||||
| funds | support | |||||
| E | ||||||
| Bookkeeping | and administration | fees | 528 | 588 | 1,200 | |
| Rent | 13,226 | 2,104 | 14I729 | 30,059 | ||
| Office costs | 77,080 | 12,263 | 85I839 | 175,182 | ||
| Sundry | 333 | 53 | 369 | 755 | ||
| Governance | costs (see note 8) | 29,799 | 4,741 | 33,186 | 67,726 | |
| 120,966 | 19,245 | 134,711 | 274,922 |
| Total | Total | |||
|---|---|---|---|---|
| 2023 | 2022 | |||
| Auditor's | remuneration | 4,774 | 4,203 | |
| Accountancy | fees | 3,082 | 2,788 | |
| Professional | fees | 24,238 | 31,251 | |
| Salaries | 35,299 | 25,739 | ||
| Trustees' | Meetings | 333 | 51 | |
| 67,726 | 64,032 |
| Analysis ofgrants | ||||
|---|---|---|---|---|
| Grants to | Direct | Support | Total | |
| Institutions | costs | costs | ||
| E | ||||
| Prof5Gentleman | 133,103 | 133,103 | ||
| Prof A Lowit | 98,629 | 98,629 | ||
| Prof C Proultakis | 128,954 | 128.954 | ||
| Dr V Cheiban | 87,280 | 87,280 | ||
| 447,966 | 447,966 |
| . Staff costs e average number ofpersons employed by the charity during |
the year was: | |
|---|---|---|
| Total | Total | |
| '2023 | 2022 | |
| E | ||
| Office staff | 10 | |
| Specialist nurses | 6 | |
| Advocacy Office/Social Welfare Specialist | 1 | |
| 17 | 15 |
| . Staffcosts (continued) |
||
|---|---|---|
| Total | Total | |
| 2023 | 2022 | |
| Gross wages | 545,896 | 482,177 |
| Social security | 50,064 | 42,317 |
| Pension costs | 25,701 | 24,041 |
| 621,661 | 548,535 |
| Office | Patient | Total | ||
|---|---|---|---|---|
| equipment | Aids | |||
| E | ||||
| Cost or valuation | ||||
| At April 2022 | 29,254 | 57,577 | 86,831 | |
| Additions | 2,492 | 2,492 | ||
| Disposals | (289) | (289) | ||
| At31March | 2023 | 31,457 | 57,577 | 89,034 |
| Depreciation | ||||
| At April 2022 | 19,285 | 55,442 | 74,727 | |
| Charge forthe year | 3,646 | 1,710 | 5,356 | |
| Elimination | on disposal | (289) | (289) | |
| At 31March | 2023 | 22,642 | 57)152 | 79,794 |
| Net BookVa(ue | ||||
| At 31Iviarch | 2023 | 8,815 | 425 | 9,240 |
| At 31IVlarch | 2022 | 9,969 | 2,135 | 12,104 |
| AR ENDED 3 2.Investments |
1MARCH | 20 | 23 | ||
|---|---|---|---|---|---|
| Total | |||||
| 2023 | |||||
| Cost or valuation | |||||
| At 1April 2022 | 2,433,525 | ||||
| Additions | 18,375 | ||||
| Disposals | |||||
| Revaluation | (12,440) | ||||
| At 31March | 2023 | 2,439,460 | |||
| Impairment | |||||
| At 1April 2022 and 31March 2023 | |||||
| Carrying amount | |||||
| At 31March | 2023 | 2,439p460 | |||
| At 31Iviarch | 2022 | 2,433,525 | |||
| Market | |||||
| Cost | Value | ||||
| 31March | 31March | ||||
| 2023 | 2023 | ||||
| The Trustees' | Investments | were made up as | |||
| follows: | |||||
| CCLA | 2,005,027 | 2,439,460 | |||
| 2,005,027 | 2,439,460 | ||||
| 31March | 31March | ||||
| 2023 | 2022 | ||||
| Investments | at fair value | compdse: | |||
| Equities | 1,102,135 | 1,114,575 | |||
| Cash with Investment | portfolio | 1,337,325 | 1,318,950 | ||
| 2,439,460 | 2,433,525 |
| 2023 | 2022 |
|---|---|
| 6 | |
| 13,012 | 8,505 |
| .Stock | 2023 |
2022 6 |
|---|---|---|
| Finished goods: Merchandise | 13,012 | 8,505 |
| ,Debtors | ||
| 2023 | 2022 | |
| E | ||
| Other debtors | 125,694 | 22,345 |
| Accrued income | 20,000 | 42,529 |
| 145,694 | 64,874 |
| .Cash at ban'k | ||||||
|---|---|---|---|---|---|---|
| Unrestricted | Restricted | Total | Total | |||
| Income | income | funds | funds | |||
| funds | funds | 2023 | 2022 | |||
| E | E | |||||
| Cash committed | for | research grant funding | ||||
| Other cash | ?70,321 | 270,321 | 339,096 | |||
| 270,321 | 270,321 | 339,096 | ||||
| .Creditors: amounts | falling due within one year | |||||
| 2023 | 2022 | |||||
| E | E | |||||
| Accrual for research | grants | 222,018 | 209,801 | |||
| Ot'her taxation | and | social security | 13,512 | 10,722 | ||
| Ot'her creditors | 28,619 | 19,264 | ||||
| 264,149 | 239,787 |
| ,Credit | ors: | amounts | falling due after mora than one | year | |
|---|---|---|---|---|---|
| 2023 | 2022 | ||||
| E | |||||
| Accrual | for | Research | grants | 239,508 | 239,365 |
| 8, Reconciiiat |
ion o | fnet move | ment in funds tonet cash flo |
w from operating activities |
|
|---|---|---|---|---|---|
| Total | Total | ||||
| funds | funds | ||||
| 2023 | 2022 | ||||
| E | E | ||||
| Movement in |
net funds | (4,882) | 270,551 | ||
| Depreciation | oftangible fixed | assets | 5,356 | 4,629 | |
| Interest receivable | {23,992) | (535) | |||
| (Gains)/losses | on investments | 12,440 | (104,6581 | ||
| Decrease/(increase) | ln stocks | (4,507) | (935) | ||
| Decrease/(Increase) | in debtors | (80,820) | 178,335 | ||
| Increase/(Decrease) | in creditors | 24,505 | (193,336) | ||
| Net cash flow | from | operating | activities | (71,900) | 154,051 |
| Total | Total | |||
|---|---|---|---|---|
| funds | funds | |||
| 2023 | 2022 | |||
| Within | one | year | 2,404 | 2,404 |
| Within | one | to five years | 2,916 | 5,320 |
| 5,320 | 7,724 |
| Research | hiurse | Regin nai | Other | Total | Total | |
|---|---|---|---|---|---|---|
| specialists | Core | 2023 | 2022 | |||
| E | E | E | ||||
| Brought forward funds | 282,167 | 282,167 | 244,710 | |||
| Income arising in the year | 317&726 | 36,951 | 49,068 | 94,250 | 497,995 | 474,364 |
| Expenses paid during the year | (447,966) | (36,951) | (49,068) | (94,250) | (628,235) | (436,907) |
| Carried forward funds | 151,927 | 151,927 | 282,167 |
| .Analysis | o | ffunds | ||||||
|---|---|---|---|---|---|---|---|---|
| At1April | Incoming | Resources | Gains | At31 | ||||
| 2022 | resources | expended | and | March | ||||
| losses | 2023 | |||||||
| E | f. | |||||||
| Analysis of | movements | in funds | ||||||
| Unrestricted | fund | 2,096,785 | 865,330 | (727,532) | (12,440) | 2,222,143 | ||
| Restricted | fund | 282,167 | 497,995 | (628,235) | 151,927 |
| Fixed | Net | Non- | Total | |||
|---|---|---|---|---|---|---|
| assets | current | current | ||||
| assets | creditors | |||||
| E | E | E | E | |||
| Unrestricted | fund | 1,835,247 | 386,896 | 2,222,143 | ||
| Restricted | fund | 613,453 | (222,018) | (239,508) | 151,927 | |
| 2+48,700 | 164,878 | (239,508) | 2,374,070 |
| Financia | I assets | 2023 | 2022 |
|---|---|---|---|
| Other debtors | 125,694 | 22,345 | |
| 125,694 | 22,345 | ||
| Financial | liabilities | 2023 | 2022 |
| Research | grants | 461526 | 449,166 |
| Other creditors | 42,131 | 29,986 | |
| 503,657 | 479,153 |
| ir transaction value and subsequently measure closing quoted market price: |
d at their fair value as at the balance she |
et date usin |
|---|---|---|
| Financial assets | 2023 | 2022 |
| E | ||
| Investments | 2,439,460 | 2,433,525 |